Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients

Journal of the Medical Association of Thailand

Volumn 87, Issue 6, 2004, Pages 674-678

  Moleerergpoom, Worachat ^a   Sura, Thunyachai ^b   Sritara, Piyamitr ^b  

^a POLICE GENERAL HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; THAILAND; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; STATISTICAL MODEL;

CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; SEROEPIDEMIOLOGIC STUDIES; THAILAND; VITAMIN B 12;

EID: 3543068114     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Carson NAJ, Neill DW: Metabolic abnormalities detected in survey of mentally backward individuals in Northern Ireland. Arch Dis Child 37: 505-13, 1962.
2. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996; 143: 845-59.
3. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr. Homocysteine and coronary artery disease in French Canadian subjects; relation with vitamin B12, B6, pyridoxal phosphate, and folate. Am J Cardiol. 1995; 75: 1107-11.
4. Selhup J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intakes as a primary determinants of homocysteinemia in an elderly population. JAMA. 1993; 270: 2693-8.
5. Ubbink LB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993; 57: 47-53.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: propable benefits of increasing folic acid intakes. JAMA. 1995; 274: 1049-57.
7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997; 337: 230-6.
8. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA. 1995; 274: 1526-33.
9. Stampfer MJ, Malinow MR, Kang SS, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CN. A prospective study of plasma homocysteine and risk of myocardial infarction in US physician. JAMA. 1992; 268: 877-81.
10. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
11. Coull BM, Malinow MR, Beamer N, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 1990; 21: 572-6.
12. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stempfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994; 25: 1924-30.
13. Den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteine and venous thrombosis: A meta-analysis. Thromb Haemos 1998; 80: 874-7.
14. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
15. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 1997; 277: 1775-81.
16. Malinow MR, Kang SS, Taylor LM, et al. Prevalence of hyperhomocysteinemia in patient with peripheral arterial occlusive disease. Circulation 1989; 79: 1180-8.
17. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): Population reference ranges and concentration of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331-9.
18. Hankey GJ, Eikeboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407-13.
19. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 1998; 316: 894-8.
20. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PMHomocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993 Feb 39: 263-71.
21. Refsum H, Ueland PM, Svardal AM. (1989) Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 35: 1921-7.
22. Ubbink JB, Hayward Vermaak WJ, Bissbort S. (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr 565: 441-6.